- Report
- April 2026
- 342 Pages
Global
From €5177EUR$5,850USD£4,510GBP
- Report
- February 2026
- 250 Pages
Global
From €3973EUR$4,490USD£3,461GBP
- Report
- February 2026
- 250 Pages
Global
From €3973EUR$4,490USD£3,461GBP
- Report
- July 2025
- 350 Pages
Global
From €4380EUR$4,949USD£3,815GBP
- Report
- June 2025
- 400 Pages
Global
From €4380EUR$4,949USD£3,815GBP
- Report
- November 2025
- 148 Pages
Global
From €3496EUR$3,950USD£3,045GBP
- Report
- November 2025
- 160 Pages
Global
From €2971EUR$3,358USD£2,588GBP
€3496EUR$3,950USD£3,045GBP
- Report
- August 2025
- 150 Pages
Global
From €2971EUR$3,358USD£2,588GBP
€3496EUR$3,950USD£3,045GBP
- Report
- January 2026
- 160 Pages
Global
From €2972EUR$3,358USD£2,589GBP
€3496EUR$3,950USD£3,045GBP
- Report
- March 2026
- 130 Pages
Global
From €4292EUR$4,850USD£3,739GBP
- Report
- March 2026
- 135 Pages
Global
From €4292EUR$4,850USD£3,739GBP
- Report
- November 2025
- 150 Pages
Global
From €4292EUR$4,850USD£3,739GBP
- Report
- November 2025
- 150 Pages
Global
From €4292EUR$4,850USD£3,739GBP
- Report
- December 2025
Global
From €6637EUR$7,500USD£5,782GBP
- Report
- October 2025
- 98 Pages
Global
From €4292EUR$4,850USD£3,739GBP
- Report
- August 2025
- 123 Pages
North America
From €3539EUR$3,999USD£3,083GBP
- Report
- September 2024
- 427 Pages
Global
From €4381EUR$4,950USD£3,816GBP
- Report
- July 2024
- 144 Pages
Global
From €2646EUR$2,990USD£2,305GBP
- Report
- July 2019
- 266 Pages
Global
From €3097EUR$3,500USD£2,698GBP
- Report
- June 2022
- 152 Pages
Global
From €4867EUR$5,500USD£4,240GBP

The Bare Metal Stent (BMS) market is a subset of the larger stent market. BMS are medical devices used to treat narrowed or blocked arteries. They are made of stainless steel or cobalt chromium and are designed to be inserted into the artery to keep it open. BMS are used to treat a variety of conditions, including coronary artery disease, peripheral artery disease, and carotid artery disease. BMS are typically used in combination with other treatments, such as angioplasty or bypass surgery.
BMS are considered to be a cost-effective treatment option for many patients, as they are less expensive than other stent types. They are also less invasive than other treatments, making them a popular choice for many patients.
Some of the major companies in the BMS market include Abbott, Boston Scientific, Medtronic, and Biotronik. Show Less Read more